A monoclonal antibody was produced to the exterior envelope glycoprotein (gp120) of the
human T-cell lymphotropic virus (HTLV)-IIIB isolate of the human immunodeficiency virus …

Four major neutralizing regions of the human immunodeficiency virus type 1 (HIV-1)
envelope glycoprotein were identified and characterized with a panel of 80 HIV-1 antibody …

The selection of human monoclonal antibodies (MAbs) specific for human immunodeficiency
virus (HIV) type 1 by binding assays may fail to identify Abs to quaternary epitopes on the …

Two synthetic peptides containing amino acid sequences analogous to the envelope
glycoprotein of human T‐lymphotropic virus (HTLV) type III (HTLV‐III) and lymphadenopathy …

Chimpanzees are susceptible to infection by divergent strains of human immunodeficiency
virus type 1 (HIV-1), none of which cause clinical or immunological abnormalities …

Although typical primary isolates of human immunodeficiency virus type 1 (HIV-1) are
relatively neutralization resistant, three human monoclonal antibodies and a small number …

We have studied the biologic and physical properties of a monoclonal antibody that binds to
gp120, the exterior envelope glycoprotein of the human immunodeficiency virus (HIV) strain …

Cell lines secreting IgG1 human monoclonal antibodies (mAb) to the envelope glycoprotein,
gp120, of human immunodeficiency virus (HIV) have been produced by transformation of …

It is suggested that the antibody response to HIV-1 envelope proteins is not directed to virus
but instead directed to viral debris (nonnative forms of the HIV-1 envelope released by lysis …

Sera from individuals infected by HIV-1 usually neutralize multiple viral isolates. To
determine the extent to which these neutralizing antibodies recognize a principal …